Clariant`s Capital Markets & Media Days (CMMD) 2014 were held in the new Clariant Innovation Center (CIC) on Industriepark Höchst, one of the biggest chemical production clusters in Germany.

This year’s event focused on innovation as this is a vital part of Clariant’s growth strategy and the speakers gave a deeper insight into the approach to converting innovation into market success.

They shared highlights of Clariant`s global R&D approach and explained how innovation will be converted into market success and ultimately into cash.

Clariant further presented future solutions with a focus on Personal Care, Crop Solutions, Catalysts and Masterbatches.

A tour through the CIC which stands for the new Clariant was part of the program. The building is open, transparent and enables daily interaction and cross-fertilization between businesses, researchers and customers.

A visit to Clariant`s production site at the Industriepark Höchst was another highlight of the Capital Markets & Media Days 2014.

PERFORMANCE. GROWTH. INNOVATION.

Clariant confirmed mid-term targets 2015 and further shed light in the continuity of the businesses beyond 2015 at its Capital Markets Day 2013 on 28 June in London and its Media Day 2013 on 8 July in Zürich.

Both events highlighted the sustainable profitable growth strategy with a well-positioned portfolio. Performance, growth and innovation will be the key drivers for Clariant’s continued success story beyond 2015.

The dedicated media event included presentations by Hariolf Kottmann (CEO), Patrick Jany (CFO), BU Heads Michael Willome (BU Head ICS) and John Dunne (BU Head OMS), as well as breakout sessions with Mathias Lütgendorf (Member of EC), Christian Kohlpaintner (Member of EC), Martin Vollmer (Chief Technology Officer) and Ralf Zerrer (Head of Global Marketing ICS).

“The investments into R&D of the last two years are now becoming visible. The innovation pipeline is constantly growing and currently has a sales potential of more than 1 billion Swiss francs by 2017”, CEO Hariolf Kottmann said. “Combining Clariant’s innovation strength with a clear focus on customers and markets, we will be in an even better position to exploit the potential of our R&D pipeline.”

The repositioning of Industrial and Consumer Specialty to a customer-driven business and the growth opportunities of Oil and Mining like in alternative oil recovery fields were another key topic of the main event.

Breakout sessions focussed on synergies between Clariant group services and the businesses showcasing some of the most recent successes in the development of its product pipeline, such as its crop care adjuvant Synergen® or its de-emulsifier Phasetreat®, an award-winning product in oil services.

The Capital Markets Day took place on 28 June, 2013 in London, the Media Day on 8 July, 2013 in Zürich. Clariant will also host a Capital Markets Day event in New York for our US investors on 11 July, 2013.

Clariant has presented key elements of its profitable growth strategy on the occasion of the Capital Markets & Media Day 2012 on 21/22 June.

The event in Munich, Germany, highlighted some of the many growth opportunities in Clariant’s portfolio. A visit to the state-of-the-art catalyst facility underlined the advantages of having R&D to scale-up and production under one roof. The potential of Biotech expertise was explored through a visit to Clariant’s Biotech center in Munich. This R&D facility includes enzyme and micro-organism optimization, protein engineering, Ultra-High-Throughput screening and pilot plants.

The site visits were completed with a series of presentations. In order to achieve its 2015 targets, Clariant needs to make considerable progress in all four of the strategic directions defined. Within the existing business units, a further profitability increase is planned through Performance Management and Functional Excellence measures. Successful innovations will generate new growth opportunities. In addition, increased market shares in emerging markets such as China, India and Brazil will further boost profitable growth.

An active portfolio management will play an important role on the path to a sustainably profitable company. They are an important pre-requisite for reaching our targets by 2015. At that point, a newly aligned Clariant will be even more profitable and will generate more than 70% of its sales from non-cyclical business units. The acquisition of Süd-Chemie marked an important first milestone in this process. We will continue this success story in the next years.

In a nutshell - the profitable growth strategy will fundamentally change the Group in the next few years and create an even more profitable Specialty Chemicals company than that of today.